<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Powers, Jenny</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Arrondeau, Jennifer</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Brain Metastases Safely Treated with WBRT after Bevacizumab and Chemotherapy in NSCLC</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-06-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">12-12</style></pages><abstract><style  face="normal" font="default" size="100%">Patients who had brain metastases following bevacizumab and chemotherapy (CT) for non-squamous, non—small cell lung cancer (non-Sq NSCLC) were safely treated with whole-brain radiotherapy, with a good response and symptom improvement.</style></abstract><number><style face="normal" font="default" size="100%">3</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>